Mettler-Toledo International Inc. (NYSE:MTD) Shares Purchased by Axxcess Wealth Management LLC

Axxcess Wealth Management LLC grew its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 6.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 870 shares of the medical instruments supplier’s stock after purchasing an additional 55 shares during the quarter. Axxcess Wealth Management LLC’s holdings in Mettler-Toledo International were worth $1,065,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Farther Finance Advisors LLC raised its holdings in shares of Mettler-Toledo International by 14.3% during the 4th quarter. Farther Finance Advisors LLC now owns 64 shares of the medical instruments supplier’s stock valued at $78,000 after buying an additional 8 shares during the period. Townsquare Capital LLC raised its stake in shares of Mettler-Toledo International by 2.0% during the third quarter. Townsquare Capital LLC now owns 462 shares of the medical instruments supplier’s stock valued at $693,000 after purchasing an additional 9 shares during the period. M3 Advisory Group LLC lifted its position in shares of Mettler-Toledo International by 5.8% during the fourth quarter. M3 Advisory Group LLC now owns 165 shares of the medical instruments supplier’s stock worth $202,000 after purchasing an additional 9 shares in the last quarter. Apollon Wealth Management LLC grew its holdings in Mettler-Toledo International by 2.5% during the 4th quarter. Apollon Wealth Management LLC now owns 368 shares of the medical instruments supplier’s stock valued at $451,000 after purchasing an additional 9 shares in the last quarter. Finally, Steward Partners Investment Advisory LLC increased its stake in Mettler-Toledo International by 3.0% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 306 shares of the medical instruments supplier’s stock worth $374,000 after buying an additional 9 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have weighed in on MTD shares. Citigroup decreased their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating for the company in a research report on Tuesday, March 4th. Wells Fargo & Company lifted their price objective on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the stock an “equal weight” rating in a report on Monday, February 10th. Robert W. Baird increased their target price on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. Wolfe Research started coverage on shares of Mettler-Toledo International in a research note on Friday, December 13th. They issued a “peer perform” rating for the company. Finally, Evercore ISI increased their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a research note on Monday, February 10th. One analyst has rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $1,380.50.

Mettler-Toledo International Price Performance

Mettler-Toledo International stock opened at $1,200.33 on Friday. The company has a market cap of $25.11 billion, a PE ratio of 29.62, a P/E/G ratio of 3.30 and a beta of 1.15. Mettler-Toledo International Inc. has a 12 month low of $1,142.91 and a 12 month high of $1,546.93. The company has a fifty day moving average price of $1,293.03 and a two-hundred day moving average price of $1,312.51.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, beating analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. Equities research analysts anticipate that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current year.

Insider Buying and Selling

In related news, insider Gerry Keller sold 600 shares of the stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total value of $810,804.00. Following the sale, the insider now owns 6 shares of the company’s stock, valued at $8,108.04. This trade represents a 99.01 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Christian Magloth sold 790 shares of Mettler-Toledo International stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the completion of the sale, the insider now owns 734 shares in the company, valued at approximately $964,248.46. This represents a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.94% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.